Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF for Acute Muscle Tears
NCT00726245Phase 3Completed
- Sponsor
- Meir Medical Center
- Start
- Jan 2008
- Primary completion
- Feb 2009
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in muscle strain comparing PRGF with Placebo (2 arms). Primary endpoint: improvement of symptoms / disease progress at 1 year. Started Jan 2008; status: completed.
02
Drugs
PRGF-Endoret
03
Conditions
muscle strain
Beyond the preview
Go deeper on NCT00726245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00726245.